Add BrightSurf on Google Email

NIH/National Heart, Lung and Blood Institute


NHLBI study finds traditional diuretics work better than newer medicines for treating hypertension

A recent NHLBI study found that traditional diuretics are more effective than newer antihypertensive medications in treating high blood pressure and preventing cardiovascular events. The study, which involved over 42,000 participants, showed that diuretics reduced the risk of heart attacks and strokes by 34% compared to the other groups.

Study finds dramatic decline in physical activity among African-American and white girls

A recent study has revealed a significant decrease in leisure-time physical activity among black girls (56%) and white girls (31%) aged 16-17. Lower parental education levels and higher body mass indexes were found to predict activity decline in both racial groups, while pregnancy was associated with activity declines only in black girls.

SourceNIH/National Heart, Lung and Blood Institute·JournalNew England Journal of Medicine·DateSep 4, 2002

NHLBI study finds DASH diet and reduced sodium lowers blood pressure for all

A recent NHLBI study found that the DASH diet and reducing dietary sodium can lower blood pressure in diverse populations, including those with hypertension, older adults, and younger individuals. The study's findings suggest that these lifestyle changes can benefit Americans of all ages, backgrounds, and health statuses.

SourceNIH/National Heart, Lung and Blood Institute·JournalAnnals of Internal Medicine·DateDec 17, 2001

Study finds no reduction in deaths or heart attacks in heart disease patients treated for depression and low social support

A study of 2,481 patients with heart disease found that treating depression and low social support did not reduce deaths or heart attacks. Despite improvements in psychological and social functioning, patients who received treatment showed no significant change in heart disease survival over a 3-year period.

NHLBI-funded study finds heart assist device extends and improves lives of patients with end stage heart failure

A new study funded by the NHLBI shows that a type of implantable heart pump can extend and improve the lives of terminally ill patients with end stage heart failure. The HeartMate LVAD was shown to have a 52% one-year survival rate, compared to 25% for those receiving standard medical management.

SourceNIH/National Heart, Lung and Blood Institute·JournalNew England Journal of Medicine·DateNov 12, 2001

NHLBI supported study finds inhaled steroids accelerate bone loss in women with asthma -- treatment still recommended for persistent asthma

A new study published in the New England Journal of Medicine found that premenopausal women using inhaled corticosteroids for persistent asthma experience accelerated bone loss in the hip compared to those not using the medication. The study suggests a potential long-term risk of hip fractures for these women.

SourceNIH/National Heart, Lung and Blood Institute·JournalNew England Journal of Medicine·DateSep 26, 2001

NHLBI-funded emphysema study finds certain patients at high risk for death following lung surgery

Researchers have identified scientifically based selection criteria for patients seeking lung volume reduction surgery (LVRS) as a potential treatment for advanced emphysema. High-risk patients with severe lung damage and poor outcomes after surgery are no longer being enrolled in the study, but will continue to receive medical treatment.

SourceNIH/National Heart, Lung and Blood Institute·JournalNew England Journal of Medicine·DateAug 14, 2001

Reducing sodium leads to substantial drop in blood pressure, finds NHLBI study

A recent NHLBI study found that reducing sodium intake, combined with either a typical U.S. diet or the DASH diet, substantially lowered blood pressure in persons with high blood pressure and those at higher than optimal blood pressure levels. The DASH-Sodium study found that lower sodium intake resulted in lower blood pressures for bo...

SourceNIH/National Heart, Lung and Blood Institute·JournalNew England Journal of Medicine·DateJan 3, 2001

NHLBI publishes update on high blood pressure in pregnancy

The new report clarifies how to monitor and treat pregnant women with hypertension before and during pregnancy. It highlights the importance of differentiating between hypertension and preeclampsia, a condition that affects the placenta, kidney, liver, and brain, and can lead to severe complications for both mother and child.

SourceNIH/National Heart, Lung and Blood Institute·JournalAmerican Journal of Obstetrics and Gynecology·DateOct 23, 2000

Statement from Dr. Claude Lenfant on discovery of the gene for primary pulmonary hypertension

Researchers have identified a gene associated with inherited primary pulmonary hypertension, providing new avenues of study for determining its molecular basis. The discovery opens up possibilities for designing more effective therapies for this devastating condition, which affects primarily women of childbearing age.

SourceNIH/National Heart, Lung and Blood Institute·JournalAmerican Journal of Human Genetics·DateJul 20, 2000

Treating hypertension in the patient with type 2 diabetes: Statement by Claude Lenfant, M.D., Director, National Heart, Lung, and Blood Institute

The National Heart, Lung, and Blood Institute recommends a more aggressive approach to treating high blood pressure in patients with type 2 diabetes. This is based on studies showing significant reductions in diabetes-related strokes, small blood vessel damage, and deaths when blood pressure is brought under control.

SourceNIH/National Heart, Lung and Blood Institute·JournalJournal of Clinical Hypertension·DateMay 29, 2000